Non-allergic protein – $40 million investment
Improving the lives of millions that suffer from food allergies and disorders.
After analyzing the protein in detail through an AI-based platform, the goal is to remove the allergic reaction factor while leaving the function, taste and beneficial factors.
Currently, development of hypoallergenic protein factor for food related to gluten and oral drug that can enhance immune tolerance in peanut allergy patients is in progress.
Ukko
Ukko’s mission is to improve the lives of the millions that suffer from food allergies and gluten-related disorders
General Information
- Headquarters : Palo Alto, CA
- Founders : Anat Binur, Yanay Ofran
- Categories : Food and Beverage, Health Care
- Founded : 2016
- Contact : info@ukko.us
Funding
- Investors : Continental Grain Company, Fall Line Capital, Innovation Endeavors, Khosla Ventures, Leaps by Bayer, Marc Benioff, PeakBridge, Skyviews Life Science
- Funding Rounds (2) - $47.7M
- Jan 27, 2021 Series B / $40M
- Jul 24, 2017 Venture Round / $7.7M
Source: Ukko
👉• Web: https://ukko.us/
👉• Video:
0 Comments